Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010044:Outpatient Clinics, Hospital; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010919:Placebos; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D010919:Placebos; D010672:Phenytoin; D002707:Chlordiazepoxide; D010634:Phenobarbital